Innovation

226 patent families (124 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 40,366 times.

Year	Filings
2015	50
2016	55
2017	62
2018	76
2019	53
2020	48
2021	47
2022	48
2023	51
2024	47
2025	55
2026	21

Investor mix

13 investors on record; lead investors include Abingworth, Alta Partners, Flandersbio.be, Kbc; 2 have since exited.

Investor type	Count	Share
Venture capital	6	46%
Private equity	3	23%
Other / undisclosed	4	31%